A former Tesla employee was charged by a federal grand jury today of embezzling roughly $9.3 million from Elon Musk’s electric car company over the course of two years. The indictment comes as the result of an FBI inquiry.
The employee, 32-year-old Salil Parulekar, allegedly engaged in a scheme that involved diverting payments, falsifying invoices, identity theft, and impersonating an employee of one of Tesla’s suppliers, according to the United States Attorney’s Office for the Northern District of California on Thursday:
According to the indictment, Parulekar learned in January 2017 that Tesla had terminated its supplier relationship with Schwabische Huttenwerke Automotive GmbH (“SHW”). At the time of the termination, SHW had only provided a limited number of sample products, specifically, motor pumps, to Tesla. Parulekar allegedly knew the termination meant that Tesla was withholding future payments to SHW and that Parulekar was not authorized to contravene this decision. Notwithstanding these facts, Parulekar redirected a series of payments intended for another supplier, Hota Industrial Manufacturing Co., Ltd. (“Hota”), and caused them to be paid to SHW.
Parulekar is being charged with nine counts of wire fraud and one count of aggravated identity theft. According to the DOJ, each count of wire fraud carries a maximum penalty of 20 years in prison and a $250,000 fine; the maximum penalty for the aggravated identity theft charge is two years in prison and a $250,000 fine.
A LinkedIn page appearing to belong to Parulekar indicates someone by the same name worked for Tesla for more than four years, and, if the information presented there is accurate, continued to work there as recently as last December.
Gizmodo has reached out to both Tesla and the prosecution for comment and will update this article if we hear back.
Medical 3D printing. If guns and other objects can be printed now and the biotechnology industry is working on printing even living cells; why would the appearance of 3D printed drugs be surprising? It will destroy and re-design the whole pharmaceutical world, but regulation will be a huge challenge as anyone will be able to print any kind of drugs that contain patented molecules at home. Bionic ears and simpler organs will be printed at the patient’s bedside.